GeneGo has appointed Richard Brennan as director of toxicology. Brennan is a member of the American Board of Toxicology, with experience in the pharmaceutical and biotechnology industry, particularly molecular toxicology and toxicogenomics. He will lead the MetaTox Consortium, a joint industry and government effort focused on developing systems-biology tools that can predict human toxicity of new compounds. In a previous position, Brennan directed molecular and investigative toxicology at Iconix Biosciences, where he was a member of the team that delivered ToxFX, a toxicogenomics data-management and -analysis solution.
Gene Logic will pay recently appointed CEO and president Charles Dimmler $425,000 in salary plus an incentive package worth as much as 40 percent of his salary, the company disclosed in a recent filing with the US Securities and Exchange Commission.
The company also gave Dimmler an option to buy as much as 120,000 shares of the company’s common stock at $1.37 per share that will vest in four increments spread out over three years, as well as a total of 130,000 shares as bonuses if the company achieves milestones.
In addition, Joanne Smith-Farrell has resigned as senior vice president of business development and licensing at Gene Logic. She will leave her post on July 31.